Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics
作者
Danny Rischin,Stephen P. Ackland,Judith J. Smith,Madhu B. Garg,Stephen John Clarke,Michael Millward,Guy C. Toner,John Raymond Zalcberg
出处
期刊:Annals of Oncology [Elsevier BV] 日期:2002-11-01卷期号:13 (11): 1810-1818被引量:12